Pyrrolo[1,2-b]pyridazine compounds and their uses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S235000

Reexamination Certificate

active

07041671

ABSTRACT:
Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I):including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.

REFERENCES:
patent: 1085021 (1999-05-01), None
patent: 9808847 (1998-03-01), None
patent: 02072101 (2002-09-01), None
patent: 02072202 (2002-09-01), None
Chorvat et al. (J. Med. Chem. (2000), 42: 833-848).
(He et al. J. Med. Chem. (2000), 43:449-456).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolo[1,2-b]pyridazine compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolo[1,2-b]pyridazine compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[1,2-b]pyridazine compounds and their uses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3598077

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.